Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Mikart | Contract Pharma

What are you searching for?

Sign in

Search by

Mikart

Mikart

Company Headquarters

1750 Chattahoochee Ave , Atlanta, GA, 30318, US

Driving Directions Phone: View Phone Fax: View Fax
View website

Company Description

Mikart’s 45+ years of experience in oral solid and nonsterile oral liquid dosage forms and specialization in pediatric, geriatric, and controlled-substance make us the ideal contract development and manufacturing organization partner—from formulation development through commercialization.

Request more information from Mikart

Request more information from Mikart

Categories from Mikart

Analytical Methods Development
Blending
CMC (Chemistry, Manfacturing & Controls)
Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Contract Packaging
Dosage Form Development
Encapsulation
Feasibility Studies
Filling, Capsule
Fluid Bed Processing
Formulation Development
Formulation Services
Formulation, Controlled Release
Granulation
Manufacturing, Capsules
Manufacturing, Clinical Trials Supply
Manufacturing, Controlled Substances
Manufacturing, Dose Form, Non-Sterile
Manufacturing, Ethical
Manufacturing, Generics
Manufacturing, Liquids
Manufacturing, Oral Drug Delivery
Manufacturing, OTC
Manufacturing, Solid Dosage
Manufacturing, Tablets
Methods Development
Mixing & Blending
Packaging, Blister
Packaging, Blister, Cold Form
Packaging, Capsules
Packaging, Clinical Trial Materials
Packaging, Glass Bottles and Jars
Packaging, Labels
Packaging, Liquids
Packaging, OTC
Packaging, Pouches
Packaging, Samples
Packaging, Solid Dosage
Packaging, Unit Dosage
Preformulation
Process Development/Scale-Up Services
Serialization
Tablet Coating

Content From Mikart

Beyond the Pill: Unlocking the Power of Liquid Suspensions

Sponsored Content

Beyond the Pill: Unlocking the Power of Liquid Suspensions

As drug developers seek out novel solutions for geriatric and pediatric populations and patients with difficulty swallowing (dysphagia), liquid suspensions have become increasingly popular. However, while liquid suspensions have distinct advantages to pills, tablets, and traditional liquid solutions for specific patient populations, their unique formulation requirements make them highly challenging to develop and manufacture. In […]

Released By Mikart

Related Content

Breaking News

Mikart Adds Nitrogen-Purged Liquid & Suspension Suites

Facilities are now fully equipped to manufacture and package liquid products under nitrogen.

By: Charlie Sternberg

Breaking News

Mikart Adds Fette Double-Sided Tablet Presses to Bolster Production Capacity

Expands its oral solid dose manufacturing capabilities.

By: Charlie Sternberg

Breaking News

Mikart Expands Production and Packaging Capabilities

Acquires FlexPack NF-150 Horizontal Sachet-Packaging machine for clinical and commercial manufacturing.

By: Kristin Brooks

Breaking News

Mikart Invests in New Liquids and Suspensions Suite

Enhances liquid oral drug product development and manufacturing capabilities of complex formulations.

By: Tim Wright

Collaborations & Alliances

Mikart Partners with Fluid Pharma to Advance the Application of MicroCoat Technology

Will manufacture clinical trial materials using proprietary MicroCoat technology to advance new therapies.

By: Charlie Sternberg

Collaborations & Alliances

Mikart, Nano PharmaSolutions Enter GMP Manufacturing Collaboration

Mikart will manufacture clinical trial materials using NanoTransformer technology.

By: Tim Wright

Breaking News

Mikart Expands Oral Solids Production Capabilities

Acquires Korsch XM12 to meet client demands for complex formulation development and production of oral solid dose products.

By: Tim Wright

Breaking News

Nautic Partners Acquires Mikart

Michael Kallelis appointed chief executive officer

By: Kristin Brooks

Promotions & Moves

Mikart Names Darrin T. Schellin as CEO

Schellin brings 20+ years of executive leadership experience across the pharmaceutical, biotechnology, and CDMO sectors.

By: Charlie Sternberg

Contract Pharma Conference

Contract Pharma Conference

Contracting & Outsourcing 2025 Testimonial with Luis Weber of Mikart

Breaking News

Mikart Adds Nitrogen-Purged Liquid & Suspension Suites

Facilities are now fully equipped to manufacture and package liquid products under nitrogen.

By: Charlie Sternberg

Breaking News

Mikart Adds Fette Double-Sided Tablet Presses to Bolster Production Capacity

Expands its oral solid dose manufacturing capabilities.

By: Charlie Sternberg

Breaking News

Mikart Expands Production and Packaging Capabilities

Acquires FlexPack NF-150 Horizontal Sachet-Packaging machine for clinical and commercial manufacturing.

By: Kristin Brooks

Breaking News

Mikart Invests in New Liquids and Suspensions Suite

Enhances liquid oral drug product development and manufacturing capabilities of complex formulations.

By: Tim Wright

Collaborations & Alliances

Mikart Partners with Fluid Pharma to Advance the Application of MicroCoat Technology

Will manufacture clinical trial materials using proprietary MicroCoat technology to advance new therapies.

By: Charlie Sternberg

Collaborations & Alliances

Mikart, Nano PharmaSolutions Enter GMP Manufacturing Collaboration

Mikart will manufacture clinical trial materials using NanoTransformer technology.

By: Tim Wright

Breaking News

Mikart Expands Oral Solids Production Capabilities

Acquires Korsch XM12 to meet client demands for complex formulation development and production of oral solid dose products.

By: Tim Wright

Videos

Mikart’s Gus Labella

Mikart's associate director of formulation development talks about the company's services.

Breaking News

VIDEO: Mikart’s Gus Labella

Mikart's associate director of formulation development talks about the company's services.

Features

Solid Dose Processing & Packaging Trends

Mikart’s senior vice president of business development, John M. Phillips, talks trends with Contract Pharma

Breaking News

Nautic Partners Acquires Mikart

Michael Kallelis appointed chief executive officer

By: Kristin Brooks

Breaking News

Mikart Compliant with DSCSA Mandates

Partnered with Optel Vision and TraceLink to fully comply with 2017 through 2023 mandates